ArticleExperimental and therapeutic medicine2017

FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2-positive breast cancer cells.

Xue Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.